CaliberMRI announces key milestone in supporting MRI scans from 0.064T to 7T to advance standards and data quality in the age of AI

BOULDER, Colo.May 7, 2025 /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced that qCal-MR®, an integrated quality assurance (QA) software platform, now supports phantom scan analysis on more than 40 MRI scanner makes and models at a variety of field strengths including: 0.064T (Hyperfine), 0.35T (MRIdian ViewRay), 0.55T (Siemens Free.Max), 1.5T (Canon, Elekta, GE, Philips, Siemens), 3T (Canon, GE, Philips, Siemens, United Imaging), and 7T (Philips). This broad and growing platform allows multi-site comparison of scanners for clinical trials, hospital system QA/quality control (QC), and research and development (R&D).

The rapid move to quantitative MRI in parallel with the growth of Artificial Intelligence (AI) and Machine Learning (ML) advancements highlights the need for high quality data. CaliberMRI’s hardware/software phantom platform allows comparison of scanner output for an improved understanding of data quality.  See full release here.

Related Articles

ISMRM Presentation Alert: “Vendor-neutral MP2RAGE with Pulseq in VENUS: Three vendors and five scanners”

“Vendor-neutral MP2RAGE with Pulseq in VENUS: Three vendors and five scanners” will be presented by author Agah Karakuzu at ISMRM Session: “Ensuring Precision in Quantitative Imaging: Quality Assessment, Repeatability, & Reproducibility.” Stop by to learn more about this important work. Authors: Agah Karakuzu, Polytechnique Montréal, @A. Hagiwara, Juntendo University; @W. Uchida, Juntendo University; @K. Kamagata, Juntendo University; […]

New paper using CaliberMRI’s Breast Phantom: “Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting”

As we get ready for ISMRM in Hawaii, we’re highlighting the amazing work from the past year by researchers using our phantoms. Today, please see the following November 2024 paper in Frontiers : “Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting” by @Brendan Moloney, @Xin Li, Michael Hirano, Assim Saad Eddin, MD, @Jeong Youn Lim, Debosmita Biswas, Anum K., Alina Tudorica, @Isabella Li, Mary Lynn Bryant, @Courtney Wille, Chelsea Pyle, @Habib Rahbar, Su Jin Kim Hsieh, @Travis Rice-Stitt, @Suzanne Dintzis, @Amani Bashir, @Evthokia Hobbs, @Alexandra Zimmer, @Jennifer Specht, Sneha Phadke, @Nicole Fleege, James Holmes, Savannah Partridge, @Wei Huang.

Abstracts – MRinRT Conference

In case you missed it, we are sharing some interesting abstracts from the MRinRT conference held in NY last month. Reach out directly to the authors on their work! Titles listed in order as they appear in program book: “Longitudinal Diffusion-Weighted MRI for Treatment Response Assessment in Locally Advanced Rectal Cancer Patients Undergoing Short-Course Radiotherapy” […]

User Group Session April 1st: Annual Physics Testing with the CaliberMRI Mini Hybrid Phantom

Join us Tuesday, April 1st for our first 2025 User Group Session:  “Annual Physics Testing with the CaliberMRI Mini Hybrid Phantom” Guest Speaker: Norman P. Sipp, MS DABR, Chief Diagnostic Medical Physicist: Ascension Seton Network-Austin, TX With 13 hospitals and two children’s hospitals, 14 MRI units and 2 mobile units, Medical Physicist Norman Sipp is […]